Literature DB >> 7743234

Noninvasive central nervous system imaging in sickle cell anemia. A preliminary study comparing transcranial Doppler with magnetic resonance angiography.

M R DeBaun1, T A Glauser, M Siegel, J Borders, B Lee.   

Abstract

PURPOSE: We evaluated the accuracy of transcranial Doppler (TCD) and magnetic resonance angiography (MRA) as a screening modality for cerebral infarct in patients with sickle cell disease. PATIENTS AND METHODS: Twenty-four patients with sickle cell disease were assessed for a cerebral infarct. Each patient underwent neurologic examination, psychometric evaluation, magnetic resonance imaging (MRI), MRA, and TCD. Presence of a cerebral infarct was determined by an MRI and supported by neurologic and neuropsychometric evaluation. All investigators were unaware of the patient's status. Cerebral vasculature by MRA was categorized as being occluded, stenotic, or normal. The maximum TCD velocity of the right and left middle cerebral artery were assessed. Various cutoffs were used to determine the sensitivity and specificity of TCD.
RESULTS: MRA had a sensitivity and specificity of 100% and 92%, respectively. At a maximum velocity cutoff of 180 cm/s, the sensitivity and specificity of TCD were 20% and 67%, respectively. No maximum velocity on TCD produced both sensitivity and specificity > 50%.
CONCLUSION: MRA is more sensitive than TCD when the middle cerebral artery for maximum velocity is compared. Prospective evaluation is warranted to determine if TCD is useful as a screening technique for cerebral infarction in children with SCD.

Entities:  

Mesh:

Year:  1995        PMID: 7743234     DOI: 10.1097/00043426-199502000-00005

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

Review 1.  The search for genetic modifiers of disease severity in the β-hemoglobinopathies.

Authors:  Guillaume Lettre
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

Review 2.  Sickle cell disease in Africa: burden and research priorities.

Authors:  J Makani; T N Williams; K Marsh
Journal:  Ann Trop Med Parasitol       Date:  2007-01

3.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

4.  Multiple complications in a sickle cell disease patient: a case report.

Authors:  J A Olaniyi
Journal:  Clin Med Case Rep       Date:  2008-07-08

Review 5.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.